Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI
RESEARCH TOOLSreports
Holding ITCI?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 20, 2024 | Mark Neumann Evp & Cco | xxxxxxxxxxxxx | $1405047 |
| Jun 25, 2024 | Rory Riggs Director | xxxxxxxxxxxxx | $337193 |
| Feb 28, 2024 | Robert Van Nostrand Director | xxxxxxxxxxxxx | $1458650 |
| Feb 27, 2024 | Joel Marcus Director | xxxxxxxxxxxxx | $1808253 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $86845 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $232866 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $311834 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $362038 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,084,563 | Institution | 8.60% | 678,616,856 | |
| 8,633,423 | Institution | 8.17% | 644,916,698 | |
| 5,736,643 | Insider | 5.43% | 428,527,232 | |
| 4,594,875 | Institution | 4.35% | 343,237,163 | |
| 3,638,389 | Insider | 3.44% | 271,787,658 | |
| 3,596,205 | Insider | 3.40% | 268,636,514 | |
| 3,596,205 | Insider | 3.40% | 268,636,514 | |
| 2,925,245 | Institution | 2.77% | 218,515,802 | |
| 2,057,869 | Institution | 1.95% | 153,722,814 | |
| 1,716,407 | Institution | 1.62% | 128,215,603 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,633,423 | Institution | 8.17% | 644,916,698 | |
| 4,594,875 | Institution | 4.35% | 343,237,163 | |
| 2,057,869 | Institution | 1.95% | 153,722,814 | |
| 1,695,662 | Institution | 1.60% | 126,665,951 | |
| 1,219,415 | Institution | 1.15% | 91,090,301 | |
| 1,062,355 | Institution | 1.01% | 79,357,919 | |
| 1,061,603 | Institution | 1.00% | 79,301,744 | |
| 1,048,130 | Institution | 0.99% | 78,295,311 | |
| 1,010,994 | Institution | 0.96% | 75,521,252 | |
| 910,528 | Institution | 0.86% | 68,016,442 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,199,941 | Institution | 3.03% | 251,899,356 | |
| 2,530,577 | Institution | 2.39% | 199,207,021 | |
| 1,496,431 | Institution | 1.42% | 117,799,048 | |
| 1,411,006 | Institution | 1.34% | 111,074,392 | |
| 710,240 | Institution | 0.67% | 53,054,928 | |
| 549,905 | Institution | 0.52% | 41,077,904 | |
| 472,324 | Institution | 0.45% | 35,282,603 | |
| 466,107 | Institution | 0.44% | 35,009,297 | |
| 370,124 | Institution | 0.35% | 27,648,263 | |
| 322,653 | Institution | 0.31% | 24,102,179 |
FAQ
Who Owns Intra-Cellular Therapies (ITCI)?
Currently, no data Available
What percentage of Intra-Cellular Therapies (ITCI) stock is held by institutional investors?
Currently, no data Available
What percentage of Intra-Cellular Therapies (ITCI) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Intra-Cellular Therapies (ITCI)?
Vanguard owns the most shares of Intra-Cellular Therapies (ITCI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.